Advanced Enzyme Technologies Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Advanced Enzyme Technologies reported its highest-ever quarterly and annual revenue for FY26, with Q4 revenue of INR 2,034 million, up 22% YoY, and full-year revenue of INR 7,458 million, up 17%. EBITDA margin remained at 31% for both the quarter and the year, while PAT grew 69% YoY in Q4 and 30% for the full year. Management attributed the growth to strength across Human Healthcare, Animal Healthcare, Bioprocessing and Specialized Manufacturing segments, and flagged input cost inflation and U.S. market uncertainty as ongoing considerations for the coming year.